ological systems to produce chemical changes in compounds that are not their natural substrates. Biotransformation is more advantageous as compared to the corresponding chemical transformations. Biotransformation conditions are generally mild and usually do not require the protection of other functional groups. In many cases, biotransformations are stereoselective, allowing the production of enantiomerically pure compounds. We have studied the biotransformation of 1 by the plant pathogenic fungus Glomerella cingulata. In our previous studies, compound 1 was transformed to α-ionol and dihydro α-ionol 20 . Recently, it has been reported that Epicoccum purpurascens shows promise for biodiesel production 21 and can be isolated from diseased berries 22 . However, there has been no report on the biotransformation of terpenoids by E. purpurascens to date 23 . In this study, the potential of cultured cells of E. purpurascens was evaluated in the biotransformation of 1.
Experimental

General
The substrate used for the biotransformation experiments was -α-ionone 1 Fluka Chemie . Also, NMR: 500 MHz 1 H , 125 MHz 13 C , CDCl 3 with TMS as the internal standard, GC: Hewlett-Packard 5890A gas chromatograph equipped with a flame ionization detector, a cyclodextrin-β-236M-19 50 m 0.25 mm i.d. column, and a split injection of 20:1 were used. Helium was used as the carrier gas at a flow rate of 0.6 mL/min. The oven temperature was programmed to increase from 80 to 220 at a rate of 2 /min. The injector was set at 210 and the detector temperature was 220 24 . The peak area was inteAbstract: The biotransformation of terpenoid C13 norisoprenoid (±)-α-ionone (1) using the plant pathogenic fungus Epicoccum purpurascens as a biocatalyst was investigated for the production of useful novel organic compounds. There are no reported biotransformations using E. purpurascens. grated using a Hewlett-Packard HP3396 Series 2 integrator. GC-MS was carried out on a Hewlett-Packard 5890A gas chromatograph equipped with a split injector HP-5MS capillary column 30 m 0.25 mm i.d. , which was directly coupled to a Hewlett-Packard 5972A mass spectrometer. The same temperature program as described above for GC was used. Helium was used as the carrier gas with a flow rate of 1 mL/min. The temperature of the ion source was 280 , and the electron energy was 70 eV. The electron impact EI mode was used. IR spectra were obtained with a Perkin-Elmer 1760X spectrometer. CHCl 3 was used as a solvent. TLC was performed using precoated silica gel 60 F254 plates layer thickness 0.25 mm, Merck . Compounds were visualized by spraying the plates with 0.5 vanillin in 96 H 2 SO 4 followed by brief heating; CC: silica gel developed with hexane-EtOAc.
Preculture of E. purpurascens
In the preculture of E. purpurascens, spores of E. purpurascens NBRC 30392 NITE Biological Resource Center, Japan , which had been preserved on potato dextrose agar PDA at 4 , were inoculated into 100 mL of sterilized culture medium 1. in a 300-mL shaking flask, and the flask was shaken reciprocating shaker, 120 rpm at 27 for 7 d.
Time-course experiment
Precultured E. purpurascens 2 mL was transferred into a 300-mL Erlenmeyer flask containing 100 mL of culture medium and stirred ca. 120 rpm for 5 d. After the growth of E. purpurascens, 1 0.156 mmol in 0.5 mL of dimethyl sulfoxide DMSO was added to the medium and the culture was continued for 10 d. Every other day, 5 mL of culture medium was removed, salted out with NaCl, and then extracted with EtOAc. The extract was analyzed by GC. The ratios of the substrate to the metabolic products were determined via TLC on the basis of the peak areas obtained from GC-MS Fig. 1 .
Biotransformation of
-α-ionone 1 for 10 d Precultured E. purpurascens was transferred into four 1000-mL Erlenmeyer flasks containing 500 mL medium. Cultivation was carried out at 27 with stirring ca. 120 rpm for 5 d. After the growth of E. purpurascens, 150 mg of 1 in 2.5 mL of DMSO was added to the medium and the organism was cultivated for 10 d.
Isolation of metabolite
After biotransformation for 10 d, the culture medium and mycelia were separated by filtration. The medium was salted out with NaCl and extracted with EtOAc. The mycelia were also extracted with EtOAc. The EtOAc extracts were mixed and dried over Na 2 SO 4 , and the solvent was evaporated to yield the crude extract 1.02 g . The extract was chromatographed on silica-200 columns with hexane-EtOAc, and untransformed 1 360 mg was recovered.
Synthesis of four stereoisomers of α-ionol 2 from
α-ionone 1 A mixture of four stereoisomers of α-ionol 2 was obtained upon LiAlH 4 reduction of a racemic mixture of -α-ionone 1 in dry tetrahydrofuran THF in an ice bath. Under suitable conditions, four baseline-separated peaks Fig. 3a were obtained for the four stereoisomers of 2.
6SR,9RS -α-ionol 2a and 2b
Colorless oil, α 
Results and discussion
Chiral gas chromatography GC demonstrated that -α-ionone 1 was present as the 6S and 6R isomers in a 1:1 proportion. Time-course experiments were performed by incubating a small amount of 1 with E. purpurascens for 10 d. A major metabolite was detected by means of 
Highly Selective Asymmetric Reductive Biotransformation of α-Ionone by Epicoccum purpurascens
TLC, GC, and GC-MS analyses. This product was not detected in the TLC, GC, and GC-MS analyses of two controls containing either mycelia with the medium or the substrate dissolved in DMSO with the medium. No metabolic product was observed in the two controls. In addition, the biotransformation using E. purpurascens reproducibly yielded 2 under the culture conditions. Thus, it is concluded that E. purpurascens transformed 1 to 2. The time-course of the metabolites shown in Fig. 1 demonstrates that about 40 of 1 was metabolized. In order to isolate the metabolite, a large-scale incubation of 1 with E. purpurascens was carried out, and the culture was extracted as described in Section 2. Metabolites were isolated from the EtOAc extract and their structures were determined on the basis of spectral data. Compound 2 was isolated from the mixture, and its molecular formula was determined as C 13 H 22 O by means of mass spectroscopy and NMR. A hydroxyl band was detected at 3350 cm 1 in the IR spectrum, and the 1 H-and 13 C-NMR spectra of the compound indicated the presence of an alcohol group at C-9. These NMR data were found to be in agreement with the previous report 24 . Based on the spectral analyses, the compound was identified as α-ionol 2 Fig. 2 . It was expected that the four diastereoisomers of the hydroxy product Fig. 3a would be obtained using racemic 1 as a starting material. The formation of compound 2 by biotransformation was determined from chiral GC analysis using the β-cyclodextrin-based column; notably, only two major product peaks Fig. 3c representing the two enantiomers, -6S,9R -α-ionol 2a and -6R,9S -α-ionol 2b , were observed Fig. 2 . Furthermore, chiral GC shows two peaks Fig. 3c that merge into a single peak if an achiral phase is used. Thus, enzymatic hydroxylation of α-ionol 2 by the E. purpurascens strains proceeds with both high regio and stereoselectivity. The conversion ratios of the metabolites -6S,9R -2a and -6R,9S -2b were 50 and 23 , respectively. The specific rotation of the mixture of 2a and 2b was 19.52 . These results demonstrate that E. purpurascens effected the reduction of 1 to yield one major metabolite involving the reduction of the C-9 ketone position to 2. Reduction of -6S,9R -and -6R,9S -2 proceeded to generate the corresponding allylic alcohols via highly selective asymmetric reduction, which leads to the recognized stereochemistry at C-6 of the γ-position in α, β-unsaturated ketones and reduction of the ketone at C-9. The same metabolites, -6S,9R -and -6R,9S -2, were previously obtained in 6:4 ratio via biotransformation using G. cingulata 20 . However, the reductive biotransformation by E. purpurascens is characterized by higher selective asymmetry than that of G. cingulata, leading to an isomeric ratio of 7:3. Furthermore, E. purpurascens leads to the highly efficient transformation of a racemate into a single stereoisomeric product in theoretically 100 chemical yield and 100 enantiomeric excess, the specific merits and limitations of which were discussed. This conversion route reduced α, β-unsaturated ketones via enzymatic reactions catalyzed by E. purpurascens. Because the Eipcoccum species is suitable for screening specific human drug-metabolizing enzymes CYP2C9 25 , this biocatalysis may be useful as a means for screening tests. 
